Paper74389
Fragments Ba and Bb derived from guinea pig factor B of the properdin system: purification, characterization, and biologic activities.
Hamuro J and 2 others. J Immunol, 1978. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. Fragments Ba and Bb derived from guinea pig factor B of the properdin system: purification, characterization, and biologic activities. Papers, record 74389. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/74389
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Fragments Ba and Bb derived from guinea pig factor B of the properdin system: purification, characterization, and biologic activities.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Complement Factor B | Major topic |
| Enzyme Precursors | Major topic |
| Anaphylatoxins | |
| Animals | |
| Chemotaxis | |
| Guinea Pigs | |
| Histamine Release | |
| Hot Temperature | |
| Molecular Conformation | |
| Molecular Weight | |
| Trypsin |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31421081 | Development of an anti-guinea pig CD4 monoclonal antibody for depletion of CD4+ T cells in vivo. | J Immunol Methods | 2019 | https://conductscience.org/library/papers/31421081 | PubMed |
| 29040213 | Importance of the Complement Alternative Pathway in Serum Chemotactic Activity During Sepsis. | Shock | 2018 | https://conductscience.org/library/papers/29040213 | PubMed |
| 22370704 | Alternative complement pathway and factor B activities in rats with altered blood levels of thyroid hormone. | Braz J Med Biol Res | 2012 | https://conductscience.org/library/papers/22370704 | PubMed |
| 18724774 | The guinea pig as a model of infectious diseases. | Comp Med | 2008 | https://conductscience.org/library/papers/18724774 | PubMed |
| 6977607 | Low zone desensitization: a stimulus-specific control mechanism of cell response. Investigations on anaphylatoxin-induced platelet secretion. | J Exp Med | 1982 | https://conductscience.org/library/papers/6977607 | PubMed |
| 6976935 | Comparative study on biological activities of various anaphylatoxins (C4a, C3a, C5a). Investigations on their ability to induce platelet secretion. | Inflammation | 1981 | https://conductscience.org/library/papers/6976935 | PubMed |
| 3486249 | Growth-supporting activity of fragment Ba of the human alternative complement pathway for activated murine B lymphocytes. | J Exp Med | 1986 | https://conductscience.org/library/papers/3486249 | PubMed |
| 2306658 | Activation of bovine monocytes and neutrophils by the Bb fragment of complement factor B: demonstration by the uptake of 3H-deoxyglucose. | Can J Vet Res | 1990 | https://conductscience.org/library/papers/2306658 | PubMed |
| 570212 | The induction of macrophage spreading by factor B of the properdin system. | J Exp Med | 1979 | https://conductscience.org/library/papers/570212 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CFB | 629 | PubTator's text mining | https://conductscience.org/library/genes/629 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/74389
GET https://conductscience.org/api/papers/v1/74389/authors